CD44 and adenocarcinoma: Recapitulating the results of our study in conjunction with the literature, the CSCs ALDH1, BMI-1, CD44, Nanog, and SOX2 do not seem to serve as reliable novel prognostic parameters in the treatment of adenocarcinoma of the salivary glands.